A Review of SF3B1 Mutant Myelodysplastic Syndrome Subtype Mechanism, Diagnosis and Prognosis

A Review of SF3B1 Mutant Myelodysplastic Syndrome Subtype Mechanism, Diagnosis and Prognosis

QIN Xiaoyan, HE Yan, LIU Yulan, SUN Yanyan

PDF(960 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(960 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (3) : 518-521. DOI: 10.11748/bjmy.issn.1006-1703.2022.03.032

Review

A Review of SF3B1 Mutant Myelodysplastic Syndrome Subtype Mechanism, Diagnosis and Prognosis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(3): 518-521 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.03.032

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(960 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉